4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Hamartoma: new trials by email Literature Review of Hamartoma trials Research Report on Hamartoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex Cannabidiol Oral Solution [Epidiolex] - Tuberous Sclerosis Complex Associated Neuropsychiatric Disease | Phase 4 | Completed | Jazz Pharmaceuticals | 79 | 2023-06-29 | 2026-04-27 |
| A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML) Everolimus - Renal Angiomyolipoma | Phase 4 | Completed | Novartis Pharmaceuticals | 4 | 2023-05-01 | 2026-10-29 |
| Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex. Everolimus - Renal Angiomyolipoma | Phase 4 | Completed | Novartis Pharmaceuticals | 40 | 2018-11-09 | 2021-09-09 |
| Doxycycline In Lymphangioleiomyomatosis (LAM) Doxycycline, Placebo - Lymphangioleiomyomatosis, Tuberous Sclerosis | Phase 4 | Completed | University of Nottingham | 24 | 2009-07-01 | 2015-12-02 |
Tuberous Sclerosis (4) · Angiomyolipoma (2) · Lymphangioleiomyomatosis (2) · Behavior (1) · Seizures (1)
Congenital Abnormalities (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Genetic Diseases, Inborn (4) · Heredodegenerative Disorders, Nervous System (4) · Malformations of Cortical Development (4) · Malformations of Cortical Development, Group I (4) · Neoplasms (4) · Neoplasms, Multiple Primary (4) · Neoplastic Syndromes, Hereditary (4) · Nervous System Diseases (4) · Nervous System Malformations (4) · Neurocutaneous Syndromes (4) · Neurodegenerative Diseases (4) · Neoplasms by Histologic Type (3)
Everolimus (2) · Cannabidiol (1) · Doxycycline (1)
Novartis Pharmaceuticals (2) · Jazz Pharmaceuticals (1) · University of Nottingham (1)
United Kingdom (2) · Canada (1) · China (1) · Poland (1) · Taiwan (1) · United States (1)
2023 (1)